东阳光：控股股东一致行动人4000万股解质押后3500万股再质押

Core Viewpoint - The announcement reveals significant changes in the share pledging status of Yichang Pharmaceutical Co., a major shareholder of Dongyangguang, indicating a strategic move in financing and ownership structure [1] Group 1: Share Pledge and Release - Yichang Pharmaceutical Co. has released the pledge of 40 million shares, which accounts for 7.34% of its holdings and 1.33% of the total share capital of the company, with the release date set for January 16, 2026 [1] - Concurrently, Yichang Pharmaceutical Co. has pledged an additional 35 million shares, representing 6.42% of its holdings and 1.16% of the total share capital, with the financing intended for production and operations [1] - As of the announcement date, Yichang Pharmaceutical Co. has a total of 537 million shares pledged, which constitutes 98.46% of its total holdings; the controlling shareholder and its concerted parties have a cumulative pledge of 1.241 billion shares, making up 78.06% of their total holdings [1]